Evidence map›Paper›PMID 31863869›Full record

ArticleToxicology letters2020

Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.

Nikolina Maček Hrvat, Jarosław Kalisiak, Goran Šinko, Zoran Radić, K Barry Sharpless, Palmer Taylor, Zrinka Kovarik

Open access · greenAbstract readComparative Study
In one paragraph

Article in Toxicology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.International journal of molecular sciences · 2022
    Article
  4. Article
  5. Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  6. Article
  7. Article
  8. Counteracting poisoning with chemical warfare nerve agents.Arhiv za higijenu rada i toksikologiju · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Nikolina Maček HrvatInstitute for Medical Research and Occupational Health, HR-10000 Zagreb, Croatia.
Jarosław KalisiakSkaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Goran ŠinkoInstitute for Medical Research and Occupational Health, HR-10000 Zagreb, Croatia.
Zoran RadićSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA 92093-0650, United States.
K Barry SharplessSkaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Palmer TaylorSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA 92093-0650, United States.
Zrinka KovarikInstitute for Medical Research and Occupational Health, HR-10000 Zagreb, Croatia. Electronic address: zkovarik@imi.hr.
Institute for Medical Research and Occupational Health · HRScripps Research Institute · US

Funding

Oxime-Assisted Catalysis of Organophosphates and Reactivation of AChEU01NS058046 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, PALMER WILLIAM · 2006 to 2011
$4.0M
NINDS NIH HHS U01 NS058046
6 · The paper itself

Abstract

Acetylcholinesterase (AChE) is a pivotal enzyme in neurotransmission. Its inhibition leads to cholinergic crises and could ultimately result in death. A related enzyme, butyrylcholinesterase (BChE), may act in the CNS as a co-regulator in terminating nerve impulses and is a natural plasma scavenger upon exposure to organophosphate (OP) nerve agents that irreversibly inhibit both enzymes. With the aim of improving reactivation of cholinesterases phosphylated by nerve agents sarin, VX, cyclosarin, and tabun, ten phenyltetrahydroisoquinoline (PIQ) aldoximes were synthesized by Huisgen 1,3 dipolar cycloaddition between alkyne- and azide-building blocks. The PIQ moiety may serve as a peripheral site anchor positioning the aldoxime moiety at the AChE active site. In terms of evaluated dissociation inhibition constants, the aldoximes could be characterized as high-affinity ligands. Nevertheless, high binding affinity of these oximes to AChE or its phosphylated conjugates did not assure rapid and selective AChE reactivation. Rather, potential reactivators of phosphylated BChE, with its enlarged acyl pocket, were identified, especially in case of cyclosarin, where the reactivation rates of the lead reactivator was 100- and 6-times that of 2-PAM and HI-6, respectively. Nevertheless, the return of the enzyme activity was affected by the nerve agent conjugated to catalytic serine, which highlights the lack of the universality of reactivators with respect to both the target enzyme and OP structure.

Indexed as

AcetylcholinesteraseButyrylcholinesteraseCholinesterase InhibitorsCholinesterase ReactivatorsEnzyme ActivationGPI-Linked ProteinsHumansKineticsNerve AgentsOrganophosphate PoisoningOrganophosphatesOrganophosphorus CompoundsOrganothiophosphorus CompoundsOximesProtein ConformationSarinacetaldehyde oximeAcetylcholinesteraseACHE protein, humanAche protein, mouseBCHE protein, humanButyrylcholinesteraseCholinesterase InhibitorsCholinesterase Reactivatorscyclohexyl methylphosphonofluoridateGPI-Linked ProteinsNerve AgentsOrganophosphatesOrganophosphorus CompoundsOrganothiophosphorus CompoundsOximesSarintabunVX-agentAcetylcholinesteraseAntidoteButyrylcholinesteraseNerve agentOrganophosphatePeripheral anionic sitePralidoxime

Identifiers

PMID31863869
PMCPMC7053431
OpenAlexW2995230840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.